THYLOX

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: THYLOX
Generic name: SULFUR
Manufacturer: Bradford Soap Works, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: 5f52b769-9893-4391-b98f-3765e7b49485
SPL ID: 474c6832-369e-3e1d-e063-6294a90ac253
Version: 14
Effective date: 2025-12-31
Source export date: 2026-10-30
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/0b630a6825fc0c8abba22d7c8fd4d069bde78bef928766047ddbb369119f337f/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 18:58:57

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		THYLOX	openfda.brand_name
generic name		SULFUR	openfda.generic_name
manufacturer name		Bradford Soap Works, Inc.	openfda.manufacturer_name
ndc	package	11118-1002-1	openfda.package_ndc
ndc	product	11118-1002	openfda.product_ndc
ndc11	package	11118100201	derived:openfda.package_ndc
rxcui		1793760	openfda.rxcui
rxcui		248410	openfda.rxcui
spl id		474c6832-369e-3e1d-e063-6294a90ac253	id
spl set id		5f52b769-9893-4391-b98f-3765e7b49485	set_id
unii		70FD1KFU70	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation to the skin. If this occurs, only one medication should be used unless directed by a doctor. When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.